{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:51:52Z","timestamp":1776901912290,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T004142\/1"],"award-info":[{"award-number":["MR\/T004142\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016580","name":"Kennedy Trust for Rheumatology Research","doi-asserted-by":"publisher","award":["KENN 19-20-10"],"award-info":[{"award-number":["KENN 19-20-10"]}],"id":[{"id":"10.13039\/100016580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016580","name":"Kennedy Trust for Rheumatology Research","doi-asserted-by":"publisher","award":["KENN 19-20-10"],"award-info":[{"award-number":["KENN 19-20-10"]}],"id":[{"id":"10.13039\/100016580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective and design<\/jats:title>\n                <jats:p>Fatigue is a prominent symptom in the general population and may follow viral infection, including SARS-CoV2 infection which causes COVID-19. Chronic fatigue lasting more than three months is the major symptom of the post-COVID syndrome (known colloquially as long-COVID). The mechanisms underlying long-COVID fatigue are unknown. We hypothesized that the development of long-COVID chronic fatigue is driven by the pro-inflammatory immune status of an individual prior to COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Subjects and methods<\/jats:title>\n                <jats:p>We analyzed pre-pandemic plasma levels of IL-6, which plays a key role in persistent fatigue, in <jats:italic>N<\/jats:italic>\u2009=\u20091274 community dwelling adults from TwinsUK. Subsequent COVID-19-positive and -negative participants were categorized based on SARS-CoV-2 antigen and antibody testing. Chronic fatigue was assessed using the Chalder Fatigue Scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>COVID-19-positive participants exhibited mild disease. Chronic fatigue was a prevalent symptom among this population and significantly higher in positive vs. negative participants (17% vs 11%, respectively; <jats:italic>p<\/jats:italic>\u2009=\u20090.001). The qualitative nature of chronic fatigue as determined by individual questionnaire responses was similar in positive and negative participants. Pre-pandemic plasma IL-6 levels were positively associated with chronic fatigue in negative, but not positive individuals. Raised BMI was associated with chronic fatigue in positive participants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Pre-existing increased IL-6 levels may contribute to chronic fatigue symptoms, but there was no increased risk in individuals with mild COVID-19 compared with uninfected individuals. Elevated BMI also increased the risk of chronic fatigue in mild COVID-19, consistent with previous reports.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00011-023-01722-2","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:43:05Z","timestamp":1680536585000},"page":"947-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-COVID fatigue is not predicted by pre-pandemic plasma IL-6 levels in mild COVID-19"],"prefix":"10.1007","volume":"72","author":[{"given":"Maxim B.","family":"Freidin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma L.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire J.","family":"Steves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine J.","family":"Doores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Malim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccolo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet M.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Franks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Borsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Granville Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Falchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances M. K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"issue":"6","key":"1722_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carfi","year":"2020","unstructured":"Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603\u20135.","journal-title":"JAMA"},{"issue":"4","key":"1722_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626\u201331.","journal-title":"Nat Med"},{"issue":"11","key":"1722_CR3","doi-asserted-by":"publisher","first-page":"e0240784","DOI":"10.1371\/journal.pone.0240784","volume":"15","author":"L Townsend","year":"2020","unstructured":"Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS\u00a0One. 2020;15(11):e0240784.","journal-title":"PLoS\u00a0One"},{"issue":"4","key":"1722_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5114\/reum.2015.53998","volume":"53","author":"B Grygiel-Gorniak","year":"2015","unstructured":"Grygiel-Gorniak B, Puszczewicz M. Fatigue and interleukin-6 - a multi-faceted relationship. Reumatologia. 2015;53(4):207\u201312.","journal-title":"Reumatologia"},{"issue":"2","key":"1722_CR5","first-page":"131","volume":"21","author":"A Kolak","year":"2017","unstructured":"Kolak A, Kami\u0144ska M, Wysoki\u0144ska E, Surdyka D, Kieszko D, Pakie\u0142a M, et al. The problem of fatigue in patients suffering from neoplastic disease. Contemp Oncol (Pozn). 2017;21(2):131\u20135.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"1","key":"1722_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023582","volume":"100","author":"L Castelnovo","year":"2021","unstructured":"Castelnovo L, Tamburello A, Lurati A, Zaccara E, Marrazza MG, Olivetti M, et al. Anti-IL6 treatment of serious COVID-19 disease: a monocentric retrospective experience. Medicine (Baltimore). 2021;100(1): e23582.","journal-title":"Medicine (Baltimore)"},{"key":"1722_CR7","doi-asserted-by":"publisher","first-page":"825749","DOI":"10.3389\/fphar.2022.825749","volume":"13","author":"E Abidi","year":"2022","unstructured":"Abidi E, El Nekidy WS, Alefishat E, Rahman N, Petroianu GA, El-Lababidi R, et al. Tocilizumab and COVID-19: timing of administration and efficacy. Front Pharmacol. 2022;13:825749.","journal-title":"Front Pharmacol"},{"key":"1722_CR8","doi-asserted-by":"publisher","first-page":"105295","DOI":"10.1016\/j.psyneuen.2021.105295","volume":"131","author":"N Kappelmann","year":"2021","unstructured":"Kappelmann N, Dantzer R, Khandaker GM. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. 2021;131:105295.","journal-title":"Psychoneuroendocrinology"},{"key":"1722_CR9","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1038\/s41380-021-01188-w","volume":"26","author":"Y Milaneschi","year":"2021","unstructured":"Milaneschi Y, Kappelmann N, Ye Z, Lamers F, Moser S, Jones PB, et al. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry. 2021;26:7393\u2013402.","journal-title":"Mol Psychiatry"},{"key":"1722_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.psyneuen.2018.11.032","volume":"100","author":"A Russell","year":"2019","unstructured":"Russell A, Hepgul N, Nikkheslat N, Borsini A, Zajkowska Z, Moll N, et al. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology. 2019;100:276\u201385.","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl 1","key":"1722_CR11","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4-9.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"1722_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1474-9726.2012.00849.x","volume":"11","author":"DB Bartlett","year":"2012","unstructured":"Bartlett DB, Firth CM, Phillips AC, Moss P, Baylis D, Syddall H, et al. The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell. 2012;11(5):912\u20135.","journal-title":"Aging Cell"},{"issue":"6","key":"1722_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1375\/twin.4.6.464","volume":"4","author":"T Andrew","year":"2001","unstructured":"Andrew T, Hart DJ, Snieder H, de Lange M, Spector TD, MacGregor AJ. Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res. 2001;4(6):464\u201377.","journal-title":"Twin Res"},{"issue":"6","key":"1722_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1017\/thg.2019.65","volume":"22","author":"S Verdi","year":"2019","unstructured":"Verdi S, Abbasian G, Bowyer RCE, Lachance G, Yarand D, Christofidou P, et al. TwinsUK: the UK adult twin registry update. Twin Res Hum Genet. 2019;22(6):523\u20139.","journal-title":"Twin Res Hum Genet"},{"key":"1722_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.12688\/wellcomeopenres.16671.1","volume":"6","author":"A Suthahar","year":"2021","unstructured":"Suthahar A, Sharma P, Hart D, Garc\u00eda MP, Horsfall R, Bowyer RCE, et al. TwinsUK COVID-19 personal experience questionnaire (CoPE): wave 1 data capture April-May 2020. Wellcome Open Res. 2021;6:123.","journal-title":"Wellcome Open Res."},{"issue":"10","key":"1722_CR16","doi-asserted-by":"publisher","first-page":"e01694","DOI":"10.1128\/JCM.01694-20","volume":"58","author":"P Muench","year":"2020","unstructured":"Muench P, Jochum S, Wenderoth V, Ofenloch-Haehnle B, Hombach M, Strobl M, et al. Development and validation of the Elecsys Anti-SARS-CoV-2 immunoassay as a highly specific tool for determining past exposure to SARS-CoV-2. J Clin Microbiol. 2020;58(10):e01694-e1720.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"1722_CR17","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","volume":"5","author":"J Seow","year":"2020","unstructured":"Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020;5(12):1598\u2013607.","journal-title":"Nat Microbiol"},{"issue":"1","key":"1722_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/occmed\/kqu168","volume":"65","author":"C Jackson","year":"2015","unstructured":"Jackson C. The Chalder fatigue scale (CFQ 11). Occup Med (Lond). 2015;65(1):86.","journal-title":"Occup Med (Lond)"},{"issue":"1","key":"1722_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jpsychores.2009.10.007","volume":"69","author":"M Cella","year":"2010","unstructured":"Cella M, Chalder T. Measuring fatigue in clinical and community settings. J Psychosom Res. 2010;69(1):17\u201322.","journal-title":"J Psychosom Res"},{"issue":"8","key":"1722_CR20","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1017\/S0033291712002437","volume":"43","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Kivimaki M, Bower JE, Irwin MR. Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study. Psychol Med. 2013;43(8):1773\u201383.","journal-title":"Psychol Med"},{"issue":"7568","key":"1722_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","volume":"333","author":"I Hickie","year":"2006","unstructured":"Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575.","journal-title":"BMJ"},{"issue":"8","key":"1722_CR22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/archinte.165.8.910","volume":"165","author":"W Lim","year":"2005","unstructured":"Lim W, Hong S, Nelesen R, Dimsdale JE. The association of obesity, cytokine levels, and depressive symptoms with diverse measures of fatigue in healthy subjects. Arch Intern Med. 2005;165(8):910\u20135.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1722_CR23","first-page":"847","volume":"83","author":"SK Fried","year":"1998","unstructured":"Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83(3):847\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"1722_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpsychores.2015.12.006","volume":"81","author":"SM Collin","year":"2016","unstructured":"Collin SM, Nikolaus S, Heron J, Knoop H, White PD, Crawley E. Chronic fatigue syndrome (CFS) symptom-based phenotypes in two clinical cohorts of adult patients in the UK and The Netherlands. J Psychosom Res. 2016;81:14\u201323.","journal-title":"J Psychosom Res"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-023-01722-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-023-01722-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-023-01722-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T15:11:02Z","timestamp":1684509062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-023-01722-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1722"],"URL":"https:\/\/doi.org\/10.1007\/s00011-023-01722-2","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}